title: [The effects of intranasal application of low dose buserelin in women with hypothalamic amenorrhea].
abstract: Low doses of the Gn-RH agonist (buserelin, 30 micrograms) were given intranasally to 14 women with clomiphene ineffective hypothalamic amenorrhea three times daily for three weeks in order to study pituitary responses and to induce follicular maturation and ovulation. Clomiphene ineffective hypothalamic amenorrhea patients were classified into two groups by LH-RH stimulation test before the treatment. Group 1 was defined as having basal serum LH and FSH levels lower than 1.5 mIU/ml, LH and FSH peaks lower than 3mIU/ml by LH-RH stimulation test. Group 2 consisted of cases other than those in Group 1. While a significant increase in basal LH and FSH (p less than 0.01, p less than 0.001) and improvement in pituitary response to LH-RH stimulation test were observed in group 1, the basal levels of LH and FSH did not increase significantly and pituitary response to a LH-RH stimulation test was decreased in group 2. It is suggested that pituitary priming occurred in group 1 and pituitary desensitization occurred in group 2. None of 14 patients showed signs of follicular maturation during or after the treatment. The results demonstrated that the biphasic pituitary response to intranasal buserelin spray and the limit of its therapeutic use for the treatment of hypothalamic amenorrhea.
authors.affiliation: Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo.
authors.forename: H
authors.initials: H
authors.lastname: Takeuchi
authors.forename: C
authors.initials: C
authors.lastname: Okabe
authors.forename: M
authors.initials: M
authors.lastname: Iida
authors.forename: M
authors.initials: M
authors.lastname: Fukuda
authors.forename: M
authors.initials: M
authors.lastname: Takada
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000568:Amenorrhea / Q000097:blood / Q000188:drug therapy*; D002064:Buserelin / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D010062:Ovulation Induction; D010902:Pituitary Gland / Q000187:drug effects; D010908:Pituitary Hormones, Anterior / Q000097:blood
chemical_list: D010908:Pituitary Hormones, Anterior; D002064:Buserelin